Clinical Study
Alzheimer’s Disease: Screening Biomarkers Using Frequency Doubling Technology Visual Field
Table 1
Characteristics of control participants.
| | Age | Gender | Race | OD
VA | OS
VA | MMSE | FDT
OD | FDT
OS | Reliability | Eye diagnosis |
| | Participants receiving eye screening | | 60 | Female | Cau | 10/10 | 10/10 | | Pass | Pass | 0/0 | None | | 63 | Female | Cau | 10/10 | 10/10 | | Pass | Pass | fx2/fx2fn1 | CA | | 63 | Male | Cau | 10/40 | 10/20 | | Pass | Pass | 0/fx1 | Card/DM | | 66 | Female | Cau | 7/10 | 7/10 | | Pass | Pass | 0/0 | Laser | | 66 | Female | Cau | 7/10 | 7/10 | | Pass | Pass | 0/0 | None | | 69 | Female | AfrAm | 7/10 | 7/10 | | Pass | Pass | 0/0 | None | | 72 | Female | AfrAm | 7/10 | 7/10 | | Pass | Pass | 0/0 | None | | 73 | | Cau | 7/10 | 7/10 | | Pass | Pass | 0/0 | None | | 78 | Male | Cau | 10/20 | 10/20 | | Pass | Fail | 0/fx1 | DM |
| | Participants receiving comprehensive dilated eye examination and refraction | | 71 | Male | Cau | Pass | Pass | 30 | Pass | Fail | 0/0 | Eye exam WNL | | 75 | Male | Cau | Pass | Pass | 30 | Pass | Pass | 0/0 | Eye exam WNL | | 78 | Female | Cau | Pass | Pass | 30 | Pass | Pass | 0/fx2fp1 | OD WNL OS ptosis | | 81 | Female | Cau | Pass | Pass | 30 | Fail | Pass | 0/0 | OD ptosis OS ptosis | | 81 | Female | Cau | Pass | Pass | 30 | Fail | Fail | 0/0 | Glaucoma |
|
|
